Care Health Insurance Limited, a material subsidiary of Religare Enterprises , has allotted ₹100 crore worth of non-convertible debentures. The issuance was completed on September 18, 2026, at par value.

The securities carry a fixed coupon rate of 10% per annum and are structured as unsecured, subordinated, listed, taxable, rated, redeemable, non-cumulative, and non-convertible debentures. They qualify as 'Subordinated Debt' under IRDAI laws and SEBI NCS Regulations.

Issue Structure

The company issued 10,000 debentures, each with a face value of ₹1,00,000. The issue was conducted via private placement in dematerialized form. Key terms include:

Redemption and Interest Terms

The debentures mature on September 18, 2036, subject to a call option exercisable by the issuer at the end of five years and annually thereafter. Interest is paid annually and charged to the profit and loss account.

Payment of interest is conditional upon IRDAI regulations. The issuer is not liable to pay interest if prohibited by law or if payment would result in a net loss, increase existing net losses, or cause the solvency margin to fall below the Control Level of Solvency. Missed interest payments are non-cumulative and do not constitute an event of default, though dividend distribution to equity shareholders is restricted during such periods.

Religare Enterprises has appointed Rajender Mohan Malla as Non-Executive Chairperson for the quarter ending December 31, 2026. The Board of Directors approved the continuation through a resolution by circulation on September 14, 2026.

The appointment follows a rotational policy adopted by the Board, wherein one director serves as Chairperson for each calendar quarter. Mr. Malla, an Independent Director, previously held the position from July 1, 2026, to September 30, 2026.

Governance Structure

The company informed the National Stock Exchange and BSE Limited of the decision in a corporate communication dated September 14, 2026. This update references earlier disclosures made on February 13, 2025, regarding the rotational chairperson framework.

Babu Rao P., Group General Counsel & Group Chief Compliance Officer, signed the communication. The appointment ensures continuity in leadership for the fourth quarter of FY27.